Meningococcal Vaccines Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Meningococcal Vaccines Market size is expected to grow at an annual average of 8% during 2021-2027. Invasive meningococcal disease (IMD) is a bacterial infection caused by the gram-negative cocci, Neisseria meningitidis, and includes a variety of infections, including meningitis, bacteremia (meningococcalemia), and bacteremic pneumonia. Meningococcal disease is rare, but if left untreated, it is associated with a high mortality rate of up to 50% and often causes serious complications thereafter. Meningococcal meningitis causes intimal infections of the brain and spinal cord and has the potential to cause widespread as well as endemic diseases. The disease is usually transmitted through direct contact with respiratory or throat secretion droplets from a patient or asymptomatic carrier. The various serotypes of N. meningitidis are included in 12 serogroups, of which only 5 serogroups, including A, B, C, W and Y, cause most diseases worldwide. However, the circulation of these serogroups is highly unpredictable and varies over time by age group and region. Vaccines for each of these serogroups are commercially available.

The following segmentation are covered in this report:

By Vaccine Type

• Conjugate
• Polysaccharide
• Subcapsular

By End User

• Pediatric
• Adult
• Travelers

By Vaccine Serotype

• MenACWY
• MenB & Manic
• MenC
• MenA
• MenAC

Company Profile

• Sanofi Pasteur Inc.
• GlaxoSmithKline
• Wyeth Pharmaceuticals

Scope of the report

The research study analyses the Meningococcal Vaccines Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Meningococcal Vaccines Market Report

• What was the Meningococcal Vaccines Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Meningococcal Vaccines Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.